.png){kind=logo}
Huawei is taking its health-monitoring ambitions beyond smartwatches. The company has officially introduced its first continuous glucose monitoring (CGM) system, giving users a dedicated device to track glucose levels throughout the day.
Named the Huawei Visen G1, the device is designed to attach directly to the skin and send glucose readings to compatible Huawei smartphones and smartwatches. It can also alert users when glucose levels move outside specified ranges.
The announcement is a notable change for Huawei, whose earlier smartwatch features focused mainly on assessing the risk of elevated blood sugar rather than directly measuring glucose levels. A dedicated CGM system offers a different approach, providing continuous readings instead of relying on occasional assessments.
Unlike a conventional finger-prick test, a CGM device uses a sensor placed under the skin to monitor glucose in interstitial fluid, the liquid surrounding the body's cells. Early reports suggest that Huawei's system uses a soft sensor needle, glucose oxidase, and electrodes to track changes in glucose levels.
Also Read: Best Fitness Band Deals on Flipkart: Save Up to 46% on Noise, Pebble & Huawei
The information is then sent to connected devices, allowing users to follow their readings without repeatedly checking them manually. The system is also expected to support continuous monitoring and alerts for abnormal glucose levels. However, Huawei has not yet released complete details about its accuracy, pricing, or commercial availability.
The launch follows an important regulatory development in China. Huawei's continuous glucose monitoring system appeared in medical-device approval records published on October 30. It received Class III classification, the highest category in China's medical-device regulatory system.
Huawei has been working on glucose-monitoring technology for several years. The company previously introduced blood-sugar risk assessment features in its wearable devices, but the Visen G1 marks a shift toward dedicated medical monitoring hardware.
Also Read: DeepSeek, Huawei Build 128-Chip AI System to Challenge Nvidia
The device's international availability and compatibility with products outside Huawei's ecosystem remain unclear. Its real-world performance will also matter as the company enters a market already served by established CGM manufacturers.